AVITA Medical, Inc.
RCEL
$7.15
-$0.365-4.86%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -64.03% | -86.01% | -48.24% | -102.36% | -31.98% |
| Total Depreciation and Amortization | 118.72% | 89.02% | 39.73% | 50.37% | 43.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 1.18% |
| Total Other Non-Cash Items | 194.38% | 163.43% | 77.62% | 17.60% | -386.70% |
| Change in Net Operating Assets | -24,966.67% | 181.27% | 84.68% | -87.26% | -98.93% |
| Cash from Operations | 25.61% | 19.61% | -40.42% | -129.96% | -216.15% |
| Capital Expenditure | -444.59% | -649.00% | -786.96% | -303.87% | -322.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 107.16% | -49.90% | -19.17% | -14.99% | -1,746.11% |
| Cash from Investing | 104.31% | -66.02% | -32.30% | -19.81% | -1,714.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 52.39% | 67.83% | 396.49% | 269.01% | -25.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -97.41% | 67.83% | 396.49% | 269.01% | 4,286.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -102.27% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.03% | -91.12% | -94.69% | -152.27% | -408.51% |
